Costimulation mediated by the CD28 molecule plays an important role in
optimal activation oi T cells. However, CD28-deficient mice call moun
t effective T cell-dependent immune responses, suggesting the existenc
e of other costimulatory systems. In a search for other costimulatory
molecules on T cells, we have developed a monoclonal antibody (mAb) th
at call costimulate T cells in the absence of antigen-presenting cells
(APC). The molecule recognized by this mAb, 9D3, was found to be expr
essed on almost all mature T cells and to be a protein of similar to 2
4 kD molecular mass. By expression cloning, this molecule was identifi
ed as CD9. 9D3 (anti-CD9) synergized with suboptimal doses of anti-CD3
mAb in inducing proliferation by virgin T cells. Costimulation was in
duced by independent ligation of CD3 and CD9, suggesting that colocali
zation of these two molecules is not required for T cell activation. T
he costimulation by anti-CD9 was as potent as that by anti-CD28. Moreo
ver, anti-CD9 costimulated in a CD28-independent way because anti-CD9
equally costimulated T cells from the CD28-deficient as well as wild-t
ype mice. Thus, these results indicate that CD9 serves as a molecule o
n T cells that can deliver a potent CD28-independent costimulatory sig
nal.